Clinical Trial

Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study

Study acronym: PREDiCT-NPL
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to address the significant morbidity associated with preeclampsia diagnosed after delivery. All participants will undergo biomarker evaluation with soluble fms-like tyrosine kinase-1 and placental growth factor (sFlt-1/PlGF) ratio testing before delivery to assess the predictive ability of these biomarkers with new-onset postpartum preeclampsia. High-risk participants will be randomized to a bundle of care strategies aimed at early detection and management of postpartum preeclampsia.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-21
notable Primary completion pushed: 2026-06 -> 2027-06 2026-07-21
minor Completion pushed: 2027-05 -> 2027-06 2026-07-21
Trial Details
NCT Number NCT07185204
Lead Sponsor Medical College of Wisconsin
Collaborators: Dhulikhel Hospital
Conditions Postpartum Preeclampsia
Enrollment 60 participants
Start Date 2026-03-03
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-20